SOLEUS CAPITAL MANAGEMENT, L.P. Iovance Biotherapeutics, Inc. Transaction History

SOLEUS CAPITAL MANAGEMENT, L.P. portfolio value:

$9.82M
portfolio value

SOLEUS CAPITAL MANAGEMENT, L.P. quarter portfolio value change:

-13.22%
quarter

Iovance Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +42.47% 305.6K shares 1.87M $9.58 1.02M
Q2 2022 share Increase 0.00% 719.6K shares 7.94M $11.04 719.6K